<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 4 Abdominal/Iliac/Peripheral Aneurysms | Vascular Surgery Exam Prep</title>
  <meta name="description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 4 Abdominal/Iliac/Peripheral Aneurysms | Vascular Surgery Exam Prep" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://adam-mdmph.github.io/VS-Board-Review/" />
  
  <meta property="og:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="github-repo" content="https://github.com/adam-mdmph/VS-Board-Review" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 4 Abdominal/Iliac/Peripheral Aneurysms | Vascular Surgery Exam Prep" />
  
  <meta name="twitter:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  

<meta name="author" content="Editors: Adam Johnson, MD, MPH; Matt Smith, MD, PhD; and Audible Bleeding" />


<meta name="date" content="2022-02-14" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="152x152" href="images/apple_icon.png" />
  
<link rel="prev" href="upper-extremity-and-thoracic-outlet.html"/>
<link rel="next" href="lower-extremity-occlusive-disease.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VS Board Review</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> About</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#usage"><i class="fa fa-check"></i><b>1.1</b> Usage</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#comments-questions-or-contributions"><i class="fa fa-check"></i><b>1.2</b> Comments, Questions or Contributions</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="cerebrovascular.html"><a href="cerebrovascular.html"><i class="fa fa-check"></i><b>2</b> Cerebrovascular</a>
<ul>
<li class="chapter" data-level="2.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#available-guidelines"><i class="fa fa-check"></i><b>2.1</b> Available Guidelines</a></li>
<li class="chapter" data-level="2.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#presentation-and-diagnosis"><i class="fa fa-check"></i><b>2.2</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="2.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management"><i class="fa fa-check"></i><b>2.3</b> Management</a>
<ul>
<li class="chapter" data-level="2.3.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#optimal-medical-therapy"><i class="fa fa-check"></i><b>2.3.1</b> <strong>Optimal medical therapy</strong></a></li>
<li class="chapter" data-level="2.3.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-endarterectomy"><i class="fa fa-check"></i><b>2.3.2</b> <strong>Carotid endarterectomy</strong></a></li>
<li class="chapter" data-level="2.3.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-artery-stenting"><i class="fa fa-check"></i><b>2.3.3</b> Carotid Artery Stenting</a></li>
<li class="chapter" data-level="2.3.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management-of-uncommon-disease-presentations"><i class="fa fa-check"></i><b>2.3.4</b> Management of uncommon disease presentations</a></li>
</ul></li>
<li class="chapter" data-level="2.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#prospective-trials---must-reads"><i class="fa fa-check"></i><b>2.4</b> Prospective Trials - MUST READS</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html"><i class="fa fa-check"></i><b>3</b> Upper Extremity and Thoracic Outlet</a>
<ul>
<li class="chapter" data-level="3.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy-exposure-of-vessels"><i class="fa fa-check"></i><b>3.1</b> Anatomy/ Exposure of Vessels</a></li>
<li class="chapter" data-level="3.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#epidemiology-etiology-and-diagnostic-evaluation"><i class="fa fa-check"></i><b>3.2</b> Epidemiology, etiology, and diagnostic evaluation</a></li>
<li class="chapter" data-level="3.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#operationsprocedures"><i class="fa fa-check"></i><b>3.3</b> Operations/Procedures</a></li>
<li class="chapter" data-level="3.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vaso-occlusive-disease"><i class="fa fa-check"></i><b>3.4</b> Vaso-occlusive disease</a></li>
<li class="chapter" data-level="3.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vasospastic-disorders"><i class="fa fa-check"></i><b>3.5</b> Vasospastic Disorders</a>
<ul>
<li class="chapter" data-level="3.5.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ergotism"><i class="fa fa-check"></i><b>3.5.1</b> <strong>Ergotism</strong></a></li>
<li class="chapter" data-level="3.5.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#buergers-disease"><i class="fa fa-check"></i><b>3.5.2</b> <strong>Buerger’s Disease</strong></a></li>
<li class="chapter" data-level="3.5.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#large-artery-vasculitis"><i class="fa fa-check"></i><b>3.5.3</b> <strong>Large Artery Vasculitis</strong></a></li>
</ul></li>
<li class="chapter" data-level="3.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#aneurysmal-disease"><i class="fa fa-check"></i><b>3.6</b> Aneurysmal Disease</a></li>
<li class="chapter" data-level="3.7" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#occupational-vascular-disease"><i class="fa fa-check"></i><b>3.7</b> Occupational Vascular Disease</a>
<ul>
<li class="chapter" data-level="3.7.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hand-arm-vibration-syndrome"><i class="fa fa-check"></i><b>3.7.1</b> Hand-Arm Vibration Syndrome </a></li>
<li class="chapter" data-level="3.7.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hypothenar-hammer-syndrome"><i class="fa fa-check"></i><b>3.7.2</b> Hypothenar hammer syndrome</a></li>
<li class="chapter" data-level="3.7.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#environmental-exposures"><i class="fa fa-check"></i><b>3.7.3</b> Environmental Exposures</a></li>
<li class="chapter" data-level="3.7.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#sports-medicine"><i class="fa fa-check"></i><b>3.7.4</b> Sports Medicine</a></li>
</ul></li>
<li class="chapter" data-level="3.8" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vascular-trauma-upper-extremity"><i class="fa fa-check"></i><b>3.8</b> Vascular Trauma-Upper Extremity</a></li>
<li class="chapter" data-level="3.9" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#compression-syndromes"><i class="fa fa-check"></i><b>3.9</b> Compression Syndromes</a>
<ul>
<li class="chapter" data-level="3.9.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#quadrilateral-space-syndrome"><i class="fa fa-check"></i><b>3.9.1</b> Quadrilateral space syndrome</a></li>
<li class="chapter" data-level="3.9.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#humeral-head-compression-of-axillary-artery"><i class="fa fa-check"></i><b>3.9.2</b> Humeral head compression of axillary artery</a></li>
</ul></li>
<li class="chapter" data-level="3.10" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#thoracic-outlet-syndrome"><i class="fa fa-check"></i><b>3.10</b> Thoracic Outlet Syndrome</a>
<ul>
<li class="chapter" data-level="3.10.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy"><i class="fa fa-check"></i><b>3.10.1</b> Anatomy</a></li>
<li class="chapter" data-level="3.10.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#diagnosis-and-evaluation"><i class="fa fa-check"></i><b>3.10.2</b> Diagnosis and Evaluation</a></li>
<li class="chapter" data-level="3.10.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#rib-resection-approaches"><i class="fa fa-check"></i><b>3.10.3</b> Rib Resection approaches</a></li>
<li class="chapter" data-level="3.10.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vtos"><i class="fa fa-check"></i><b>3.10.4</b> vTOS</a></li>
<li class="chapter" data-level="3.10.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#atos"><i class="fa fa-check"></i><b>3.10.5</b> aTOS</a></li>
<li class="chapter" data-level="3.10.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ntos"><i class="fa fa-check"></i><b>3.10.6</b> nTOS</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="4" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html"><i class="fa fa-check"></i><b>4</b> Abdominal/Iliac/Peripheral Aneurysms</a>
<ul>
<li class="chapter" data-level="4.1" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#pathogenesis-presentation-and-risk-factors"><i class="fa fa-check"></i><b>4.1</b> Pathogenesis, presentation and risk factors</a></li>
<li class="chapter" data-level="4.2" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#evaluation-and-diagnosis"><i class="fa fa-check"></i><b>4.2</b> Evaluation and Diagnosis</a>
<ul>
<li class="chapter" data-level="4.2.1" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#imaging"><i class="fa fa-check"></i><b>4.2.1</b> Imaging</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#management-1"><i class="fa fa-check"></i><b>4.3</b> Management</a>
<ul>
<li class="chapter" data-level="4.3.1" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#evar"><i class="fa fa-check"></i><b>4.3.1</b> EVAR</a></li>
<li class="chapter" data-level="4.3.2" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#open-repair"><i class="fa fa-check"></i><b>4.3.2</b> Open Repair</a></li>
<li class="chapter" data-level="4.3.3" data-path="abdominaliliacperipheral-aneurysms.html"><a href="abdominaliliacperipheral-aneurysms.html#ruptured-aneurysms"><i class="fa fa-check"></i><b>4.3.3</b> Ruptured Aneurysms</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html"><i class="fa fa-check"></i><b>5</b> Lower Extremity Occlusive Disease</a>
<ul>
<li class="chapter" data-level="5.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#pathophysiology"><i class="fa fa-check"></i><b>5.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="5.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#intermittent-claudication"><i class="fa fa-check"></i><b>5.2</b> Intermittent Claudication</a>
<ul>
<li class="chapter" data-level="5.2.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#history-clinical-examination"><i class="fa fa-check"></i><b>5.2.1</b> History / Clinical Examination</a></li>
<li class="chapter" data-level="5.2.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-2"><i class="fa fa-check"></i><b>5.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#chronic-limb-threatening-ischemia"><i class="fa fa-check"></i><b>5.3</b> Chronic Limb Threatening Ischemia</a></li>
<li class="chapter" data-level="5.4" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#acute-limb-ischemia"><i class="fa fa-check"></i><b>5.4</b> Acute Limb Ischemia</a>
<ul>
<li class="chapter" data-level="5.4.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#presentation-and-diangosis"><i class="fa fa-check"></i><b>5.4.1</b> Presentation and Diangosis</a></li>
<li class="chapter" data-level="5.4.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-3"><i class="fa fa-check"></i><b>5.4.2</b> Management</a></li>
<li class="chapter" data-level="5.4.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#compartment-syndrome"><i class="fa fa-check"></i><b>5.4.3</b> Compartment Syndrome</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html"><i class="fa fa-check"></i><b>6</b> Mesenteric Disease</a>
<ul>
<li class="chapter" data-level="6.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#acute-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.1</b> Acute Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.1.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-diagnosis-1"><i class="fa fa-check"></i><b>6.1.1</b> Presentation and diagnosis</a></li>
<li class="chapter" data-level="6.1.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-4"><i class="fa fa-check"></i><b>6.1.2</b> Management</a></li>
<li class="chapter" data-level="6.1.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#rare-etiologies"><i class="fa fa-check"></i><b>6.1.3</b> Rare Etiologies</a></li>
</ul></li>
<li class="chapter" data-level="6.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#chronic-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.2</b> Chronic Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.2.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-diagnosis-2"><i class="fa fa-check"></i><b>6.2.1</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="6.2.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-5"><i class="fa fa-check"></i><b>6.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="6.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#median-arcuate-ligament-syndrome-mals"><i class="fa fa-check"></i><b>6.3</b> Median Arcuate Ligament Syndrome (MALS)</a></li>
<li class="chapter" data-level="6.4" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-syndrome"><i class="fa fa-check"></i><b>6.4</b> SMA Syndrome</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="renal.html"><a href="renal.html"><i class="fa fa-check"></i><b>7</b> Renal</a>
<ul>
<li class="chapter" data-level="7.1" data-path="renal.html"><a href="renal.html#pathophysiology-1"><i class="fa fa-check"></i><b>7.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="7.2" data-path="renal.html"><a href="renal.html#medical-management-and-evaluation"><i class="fa fa-check"></i><b>7.2</b> Medical Management and Evaluation</a></li>
<li class="chapter" data-level="7.3" data-path="renal.html"><a href="renal.html#operative-managment"><i class="fa fa-check"></i><b>7.3</b> Operative Managment</a>
<ul>
<li class="chapter" data-level="7.3.1" data-path="renal.html"><a href="renal.html#endovascular-therapy"><i class="fa fa-check"></i><b>7.3.1</b> Endovascular Therapy</a></li>
<li class="chapter" data-level="7.3.2" data-path="renal.html"><a href="renal.html#open-surgery"><i class="fa fa-check"></i><b>7.3.2</b> Open Surgery</a></li>
</ul></li>
<li class="chapter" data-level="7.4" data-path="renal.html"><a href="renal.html#fibromuscular-dysplasia-fmd"><i class="fa fa-check"></i><b>7.4</b> Fibromuscular Dysplasia (FMD)</a></li>
<li class="chapter" data-level="7.5" data-path="renal.html"><a href="renal.html#renal-artery-aneurysms"><i class="fa fa-check"></i><b>7.5</b> Renal Artery Aneurysms</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html"><i class="fa fa-check"></i><b>8</b> Thoracic Aorta</a>
<ul>
<li class="chapter" data-level="8.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortic-dissection"><i class="fa fa-check"></i><b>8.1</b> Aortic Dissection</a></li>
<li class="chapter" data-level="8.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#thoracoabdominal-aneurysms-taaa"><i class="fa fa-check"></i><b>8.2</b> Thoracoabdominal Aneurysms (TAAA)</a></li>
<li class="chapter" data-level="8.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortopathies"><i class="fa fa-check"></i><b>8.3</b> Aortopathies</a>
<ul>
<li class="chapter" data-level="8.3.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#links"><i class="fa fa-check"></i><b>8.3.1</b> LINKS:</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="venous-disease.html"><a href="venous-disease.html"><i class="fa fa-check"></i><b>9</b> Venous Disease</a></li>
<li class="chapter" data-level="10" data-path="vascular-trauma.html"><a href="vascular-trauma.html"><i class="fa fa-check"></i><b>10</b> Vascular Trauma</a>
<ul>
<li class="chapter" data-level="10.1" data-path="vascular-trauma.html"><a href="vascular-trauma.html#peripheral"><i class="fa fa-check"></i><b>10.1</b> Peripheral</a></li>
<li class="chapter" data-level="10.2" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-arterial"><i class="fa fa-check"></i><b>10.2</b> Abdominal Arterial</a></li>
<li class="chapter" data-level="10.3" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-venous"><i class="fa fa-check"></i><b>10.3</b> Abdominal Venous</a></li>
<li class="chapter" data-level="10.4" data-path="vascular-trauma.html"><a href="vascular-trauma.html#cerebrovascular-trauma"><i class="fa fa-check"></i><b>10.4</b> Cerebrovascular Trauma</a></li>
<li class="chapter" data-level="10.5" data-path="vascular-trauma.html"><a href="vascular-trauma.html#endovascular-approaches"><i class="fa fa-check"></i><b>10.5</b> Endovascular Approaches</a></li>
</ul></li>
<li class="chapter" data-level="11" data-path="angioaccess.html"><a href="angioaccess.html"><i class="fa fa-check"></i><b>11</b> Angioaccess</a></li>
<li class="chapter" data-level="12" data-path="vascular-lab.html"><a href="vascular-lab.html"><i class="fa fa-check"></i><b>12</b> Vascular Lab</a>
<ul>
<li class="chapter" data-level="12.1" data-path="vascular-lab.html"><a href="vascular-lab.html#section"><i class="fa fa-check"></i><b>12.1</b> </a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="endovascular.html"><a href="endovascular.html"><i class="fa fa-check"></i><b>13</b> Endovascular</a>
<ul>
<li class="chapter" data-level="13.1" data-path="endovascular.html"><a href="endovascular.html#vascular-access"><i class="fa fa-check"></i><b>13.1</b> Vascular Access</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Vascular Surgery Exam Prep</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="abdominaliliacperipheral-aneurysms" class="section level1" number="4">
<h1><span class="header-section-number">Chapter 4</span> Abdominal/Iliac/Peripheral Aneurysms</h1>
<p><strong>30 Mar 2021:</strong> <em>Mia Miller, MD and Julie Duke, MD; University of
Minnesota</em></p>
<p><audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/VSITE_AAA_post_auphonic.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio></p>
<div id="pathogenesis-presentation-and-risk-factors" class="section level2" number="4.1">
<h2><span class="header-section-number">4.1</span> Pathogenesis, presentation and risk factors</h2>
<p><strong>What is an abdominal aortic aneurysm (AAA)?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>Defined as a localized dilation of an artery to a diameter greater
than 50% (1.5x) of its normal diameter. It is generally accepted
that &gt;3cm in adults is considered aneurysmal for the abdominal
aorta.</p></li>
<li><p>AAAs can be described as:</p>
<ul>
<li><p>Infrarenal – distal to the renal arteries with normal aorta
between the renal arteries and the aneurysm origin.</p></li>
<li><p>Juxtarenal – aneurysm extends to the renal arteries but does
not involve them</p></li>
<li><p>Pararenal – aneurysm involving the origin of at least one of
the renal arteries</p></li>
</ul></li>
<li><p>Estimated 1.1 million Americans have AAAs, which equates to a
prevalence of 1.4% in 50-84 year old general population.</p></li>
<li><p>AAAs are 3-7x more prevalent than thoracic aortic aneurysms and can
co-exist with other aneurysms throughout the arterial vascular
system like popliteal artery aneurysms.</p>
<ul>
<li><p>In a 10-year review originating from Ireland, 50% of patients
that presented with unilateral popliteal artery aneurysms had
associated AAA. In patients with bilateral popliteal aneurysms,
63% of those had associated AAA.<span class="citation"><sup>[<a href="#ref-duffyPoplitealAneurysms10year1998" role="doc-biblioref">58</a>]</sup></span></p></li>
<li><p>Conversely, if a patient is first found to have a AAA, there is
an 11% chance of having associated popliteal artery
aneurysms &gt;15mm.<span class="citation"><sup>[<a href="#ref-tuvesonPatientsAbdominalAortic2016" role="doc-biblioref">59</a>]</sup></span></p></li>
<li><p>Another study showed a rate of femoral-popliteal aneurysms in
AAA patients is approximately 14%.<span class="citation"><sup>[<a href="#ref-diwanIncidenceFemoralPopliteal2000" role="doc-biblioref">60</a>]</sup></span></p></li>
<li><p>This association stresses the importance of a good physical exam
when evaluating a patient with a AAA and is commonly tested on
exams.</p></li>
</ul></li>
</ul>
<p><strong>What is the pathogenesis of an abdominal aortic aneurysm?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>More than 90% of AAAs are associated with atherosclerosis.</p></li>
<li><p>Other causes include cystic medial necrosis, dissection, Marfan’s
syndrome, Ehler’s-Danlos syndrome, HIV and syphilis.</p></li>
<li><p>Elastin and collagen are the major structural proteins responsible
for the integrity of the aortic wall and defects in these cause
degeneration and further aneurysmal change.</p></li>
<li><p>For example, a mutation in fibrillin in Marfan’s syndrome causes
elastin fragmentation and pathological remodeling of the wall of the
artery to form cystic medial degeneration.</p></li>
<li><p>Several investigations have also shown that upregulations of
metalloproteinase activity, specifically MMP-2 and MMP-9, have an
essential role in aneurysm formation. Imbalances between aortic wall
proteases and antiproteases cause degradation of the extracellular
matrix and loss of structural integrity of the aortic wall.</p></li>
<li><p>Increased thrombus burden is associated with wall thinning, medial
loss of smooth muscle cells, elastin degradation, adventitial
inflammation and aortic wall hypoxia which all increase the rate of
AAA growth.</p></li>
</ul>
<p><strong>What are the risk factors for AAA occurrence and growth?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>Risk factors for AAAs are similar to the risk factors for occlusive
atherosclerosis and include age, tobacco use, hypertension, male
gender and hypercholesterolemia.</p></li>
<li><p>It has been found that diabetes is protective for AAA progression
and rupture.</p></li>
<li><p>Cigarette smoking is the single most important modifiable risk
factor to prevent occurrence and growth of AAAs. Smoking increases
the rate of growth by 35% for abdominal aortic aneurysms.</p></li>
<li><p>Medical therapy has been studied with disappointing results.
Beta-blockers and ACE/ARB inhibitors have been studied but have not
shown any effect on growth of AAAs.</p></li>
<li><p>Fluoroquinolones</p>
<ul>
<li><p>In a recent study just published in JAMA Surgery this January,
the group at UNC showed an increased short-term risk of
developing an aortic aneurysm with fluoroquinolone use.<span class="citation"><sup>[<a href="#ref-newtonAssociationFluoroquinoloneUse2021a" role="doc-biblioref">61</a>]</sup></span></p></li>
<li><p>They reviewed all prescription fills for fluoroquinolones or
comparative antibiotics from 2005-2017.</p></li>
<li><p>This included &gt;27 million US Adults aged 18-64 years old with no
history of aneurysms.</p></li>
<li><p>18% of the prescriptions were fluoroquinolones.</p></li>
<li><p>Fluoroquinolones were associated with increased incidence of
aortic aneurysms. Compared to the other antibiotics,
fluoroquinolones were associated with a higher 90-day incidence
of AAA and iliac aneurysms as well as more likely to undergo
aneurysm repair.</p></li>
<li><p>They recommended that fluoroquinolone use should be pursued with
caution in all adults, not just high risk individuals, and they
recommended broadening of the warnings from the FDA.</p></li>
</ul></li>
<li><p>Fluoroquinolones playing a role in dissections and aneurysm
formation is often a highly tested question</p></li>
</ul>
<p><strong>What is the dreaded complication of AAA?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>Aneurysm rupture is the fear with a diagnosis of AAA. The risk of
rupture increases yearly as the aneurysm expands. Once an aneurysm
develops, it tends to enlarge gradually yet progressively. This is
an important concept to grasp for testing.</p></li>
<li><p>Growth rate</p>
<ul>
<li><p>For smaller aneurysms (3-5cm in size), the growth rate is
approximately 2-3mm/year</p></li>
<li><p>For larger aneurysms (&gt;5cm), the growth rate is higher at
3-5mm/year.</p></li>
</ul></li>
<li><p>Rupture risk (historically):</p>
<ul>
<li><p>4 - 5.4cm -&gt; 0.5-1%.</p></li>
<li><p>6 - 7cm -&gt; 10%</p></li>
<li><p>7 – 8cm -&gt; 19-35%</p></li>
</ul></li>
<li><p>Newer data suggests the true rupture risk per year is decreasing
with time.</p></li>
<li><p>In a study from the UK published in JVS in 2015, the rupture risks
were far lower than previously reported and what is documented in
most textbooks.<span class="citation"><sup>[<a href="#ref-parkinsonRuptureRatesUntreated2015" role="doc-biblioref">62</a>]</sup></span></p>
<ul>
<li><p>This systematic review of more recently published data mostly
from 1995 to 2014 included a total of 11 studies reviewing 1514
patients. The cumulative yearly rupture risks identified in this
study were as follows:</p>
<ul>
<li><p>5.5 - 6 cm -&gt; 3.5%</p></li>
<li><p>6.1 - 7 cm -&gt; 4.1%</p></li>
<li><p>&gt;7 cm -&gt; 6.3%</p></li>
</ul></li>
<li><p>Previously published data with meta-analyses from 1970s-1990s
reported rupture rates of 3.3%, 9.4% and 24%, respectively,
compared to 3.5%, 4.1% and 6.3% in the most recent data.</p></li>
</ul></li>
<li><p>Factors that increase the risk of rupture other than the size of the
aneurysm are smoking, COPD, hypertension, transplant recipient, and
rapid enlargement (defined as 1 cm/year or more).</p></li>
</ul>
</div>
<div id="evaluation-and-diagnosis" class="section level2" number="4.2">
<h2><span class="header-section-number">4.2</span> Evaluation and Diagnosis</h2>
<p><strong>What is the work up for a AAA?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>75% of all infrarenal AAAs are asymptomatic when first detected and
often incidentally discovered on unrelated imaging.</p></li>
<li><p>Symptoms - Some patients may report symptoms such as abdominal,
flank or back pain from pressure on adjacent somatic sensory nerves
or overlying peritoneum. Tenderness by itself is not a reliable
indicator of impending rupture. Other symptoms include thrombosis
and distal embolization.</p></li>
</ul>
<div id="imaging" class="section level3" number="4.2.1">
<h3><span class="header-section-number">4.2.1</span> Imaging</h3>
<ul>
<li><p>Ultrasound, when feasible, is the preferred imaging modality for
aneurysm screening and surveillance.</p>
<ul>
<li><p>The Society for Vascular Surgery (SVS) recommends a one-time
ultrasound screening in men and women ages 65 to 75 years with
either a history of smoking or a family history of AAA, as well
as men and women over the age of 75 with a smoking history in
otherwise good health who have not previously undergone
screening.<span class="citation"><sup>[<a href="#ref-chaikofSocietyVascularSurgery2018a" role="doc-biblioref">63</a>]</sup></span> Recommended
intervals for surveillance imaging:</p>
<ul>
<li><p>2.5 – 2.9 cm -&gt; 10 years</p></li>
<li><p>3 - 3.9 cm -&gt; 3 years</p></li>
<li><p>4 - 4.9 cm -&gt; 1 year</p></li>
<li><p>5 - 5.4 cm -&gt; 6 months</p></li>
</ul></li>
<li><p>It is important to note that these screening guidelines are
Level 2, Grade C evidence from the SVS.</p></li>
<li><p>Traditionally, once duplex reveals an aneurysm 5cm in size, an
initial CTA is performed and patients are followed with
additional CT scans to assist with operative planning.</p></li>
</ul></li>
<li><p>CT Angiograms are helpful in operative planning and determining
candidacy for EVAR. You can assess the relationship of the aneurysm
to the renal arteries, assess the access vessels, and measure seal
zones</p>
<ul>
<li>The maximum aneurysm diameter derived from the CTA should be
based on outer wall to outer wall measurement perpendicular to
the path of the aorta (the centerline of the aneurysm).</li>
</ul></li>
<li><p>MRA is recommended for patients with renal insufficiency who cannot
tolerate iodinated contrast.</p></li>
</ul>
</div>
</div>
<div id="management-1" class="section level2" number="4.3">
<h2><span class="header-section-number">4.3</span> Management</h2>
<p><strong>What are the indications for repair?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>The current recommendation to repair a fusiform aneurysm is 5.5cm
for men (Level 1, Grade A evidence), 5.0cm for women as they have a
higher risk for rupture, and rapid growth (&gt;5mm over 6 months).<span class="citation"><sup>[<a href="#ref-chaikofSocietyVascularSurgery2018a" role="doc-biblioref">63</a>]</sup></span></p></li>
<li><p>For saccular aneurysms, the SVS practice guidelines recommend
elective repair (Level 2, Grade C evidence).<span class="citation"><sup>[<a href="#ref-chaikofSocietyVascularSurgery2018a" role="doc-biblioref">63</a>]</sup></span></p>
<ul>
<li><p>Studies show equivalent wall stress in saccular aneurysms at
much smaller sizes when compared to fusiform aneurysms. This has
led to the notion that they have a higher rupture risk at
smaller sizes.</p></li>
<li><p>A study published in Annals of Vascular Surgery in 2016 showed a
significant portion of ruptures &lt;55mm in size were saccular in
nature.<span class="citation"><sup>[<a href="#ref-kristmundssonMorphologySmallAbdominal2016" role="doc-biblioref">64</a>]</sup></span></p>
<ul>
<li>Specific size guidelines for repair are currently lacking
because of their infrequent presentation.</li>
</ul></li>
</ul></li>
</ul>
<p><strong>What are the options for repair, and how do you choose?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>,<a href="#ref-fairman72AortoiliacAneurysms2019" role="doc-biblioref">65</a>]</sup></span></p>
<ul>
<li><p>Two options: open repair and endovascular aortic aneurysm repair
(EVAR).</p>
<ul>
<li>When attempting to decide between the two, one must consider the
patient’s perioperative risk as well as the patient’s anatomy,
which will be reviewed further here.</li>
</ul></li>
<li><p>When reviewing the patient’s risk for surgery, there are many tools
to assist, which are outlined in the Society for Vascular Surgery’s
practice guidelines.</p></li>
<li><p>The VSGNE or Vascular Study Group of New England developed a risk
prediction model for mortality which can assist in your decision
making. This is endorsed by both SVS and the Vascular Quality
Initiative.</p>
<ul>
<li><p>This risk model looks at open vs endovascular repair and further
delineates infrarenal vs suprarenal clamps</p></li>
<li><p>It includes aneurysm sizes with 6.5cm as the cut off.</p></li>
<li><p>It includes age above or below 75yo.</p></li>
<li><p>Gender and comorbidities are included like heart disease,
cerebrovascular disease and COPD.</p></li>
<li><p>An important risk factor is also renal function which is
delineated by creatinine at 1.5-2 or &gt;2.</p></li>
<li><p>Each of these risk factors is assigned a point grading.</p></li>
<li><p>These points are added together and they place the patient on a
spectrum of mortality risk. Depending on the amount of points
accumulated, the risk is divided into low, medium, high or
prohibitively high-risk groups</p></li>
<li><p>This is something that can help both the patient and physician
in deciding on surgery and how to proceed.</p></li>
</ul></li>
<li><p>Recent studies have shown that decreased aerobic fitness and high
frailty score predicted increased morbidity and mortality after open
aneurysm repair.</p></li>
<li><p>High-risk patients are defined by the following in the SVS
guidelines:</p>
<ul>
<li><p>Unstable angina or angina at rest</p></li>
<li><p>Congestive heart failure with EF &lt; 25-30%</p></li>
<li><p>Serum creatinine level &gt; 3 mg/dL</p></li>
<li><p>Pulmonary disease manifested by room air PaO2 &lt; 50 mmHg,
elevated PCO2, or both.</p></li>
</ul></li>
<li><p>To help delineate a patient’s risk, a preoperative workup is
necessary. The SVS practice guidelines recommend the following:<span class="citation"><sup>[<a href="#ref-chaikofSocietyVascularSurgery2018a" role="doc-biblioref">63</a>]</sup></span></p>
<ul>
<li><p>Determine if the patient has an active cardiovascular condition.
Coronary artery disease is responsible for at least 50% to 60%
of perioperative and late deaths after operations on the
abdominal aorta, therefore, it is important for patients to
undergo cardiac evaluation prior to surgery.</p>
<ul>
<li><p>Unstable angina, decompensated heart failure, severe
valvular disease, significant arrythmia -&gt; Cardiology
consultation (Level 1, Grade B)</p></li>
<li><p>Significant clinical risk factors such as coronary artery
disease, congestive heart failure, stroke, diabetes
mellitus, and chronic kidney disease -&gt; Stress test (Level
2, Grade B)</p></li>
<li><p>Worsening dyspnea -&gt; Echocardiogram (Level 1, Grade A)</p></li>
<li><p>All patients undergoing EVAR or open repair require EKG</p></li>
<li><p>In patients capable of moderate physical activities, such as
climbing two flights of stairs or running a short distance
(MET &gt;= 4), there is no benefit in further testing.</p></li>
<li><p>If coronary intervention is required, this takes precedence
over aneurysm repair.</p></li>
</ul></li>
<li><p>History of COPD</p>
<ul>
<li><p>Pulmonary function test with ABG (Level 2, Grade C)</p></li>
<li><p>Smoking cessation for at least 2 weeks prior (Level 1,
Grade C)</p></li>
<li><p>Pulmonary bronchodilators at least 2 weeks before aneurysm
repair (Level 2, Grade C)</p></li>
</ul></li>
</ul></li>
<li><p>In patients who are deemed high risk, EVAR is the most attractive
option in anatomically suitable patients</p></li>
<li><p>Morbidity and mortality rates are lower for EVAR than open repair in
the short term. This is illustrated in multiple studies.</p>
<ul>
<li><p>The EVAR-1 trial, a randomized prospective UK study including
1082 patients, compared EVAR with open AAA repair in patients
who were fit enough to undergo open surgical repair from
1999-2003. The 30-day mortality rate was reduced in the EVAR
group (1.7% vs 4.7%), although secondary interventions were more
common in the EVAR group (9.8% vs. 5.8%).<span class="citation"><sup>[<a href="#ref-greenhalghComparisonEndovascularAneurysm2004" role="doc-biblioref">66</a>]</sup></span></p></li>
<li><p>The DREAM trial, a multicenter randomized trial from 2000-2003,
compared open repair with EVAR in 345 patients with a reduction
in operative mortality (4.7% vs 9.8%) with the majority of
complications accounted for by pulmonary issues.<span class="citation"><sup>[<a href="#ref-prinssenRandomizedTrialComparing2004" role="doc-biblioref">67</a>]</sup></span></p></li>
</ul></li>
<li><p>This early survival benefit with EVAR over open repair disappears by
the third postoperative year.</p>
<ul>
<li><p>The Open vs Endovascular Repair (OVER) trial included 881
patients from 42 VA centers randomized to either EVAR or open
repair. This demonstrated that perioperative mortality was
improved in the EVAR group (0.5% vs 3.0%), yet no statistically
significant difference was seen in mortality at 2 years (7.0% vs
9.8%).<span class="citation"><sup>[<a href="#ref-lederleOpenEndovascularRepair2019" role="doc-biblioref">68</a>]</sup></span></p></li>
<li><p>Late mortality seems to be higher in EVAR due to ruptures from
endoleaks that do not occur in open repair.<span class="citation"><sup>[<a href="#ref-rajendranLateRuptureAbdominal2017" role="doc-biblioref">69</a>]</sup></span></p></li>
</ul></li>
<li><p>Reviewing the anatomic criteria for traditional EVAR may rule out
EVAR as an option in some patients. These criteria vary slightly
depending on the particular device being used.</p>
<ul>
<li><p>Neck</p>
<ul>
<li><p>A neck length of at least 10-15mm from the renal arteries to
the aneurysm start with a diameter of 18-32mm.</p></li>
<li><p>It is important that the neck is relatively free of thrombus
or calcification to decrease the risk of endoleaks.</p></li>
<li><p>More complex options like fenestrated EVAR are available for
shorter necks but will not be discussed in this review.</p></li>
</ul></li>
<li><p>Angulation</p>
<ul>
<li>Neck angulation should be &lt; 60 degrees for current devices</li>
</ul></li>
<li><p>Access vessels</p>
<ul>
<li>Access vessels must be adequate for delivery of the device
depending on the sheath size required (6-8mm)</li>
</ul></li>
<li><p>Aortic bifurcation</p>
<ul>
<li>The aortic bifurcation must be &gt;20mm in size to accommodate
the graft opening to full caliber</li>
</ul></li>
<li><p>Iliac landing zone</p>
<ul>
<li><p>Adequate seal zone in the distal common iliac arteries of
10-15mm in length and diameter of 7.5-25mm.</p></li>
<li><p>If covering the hypogastric arteries is necessary
unilaterally to obtain a seal, you can embolize the
hypogastric artery (to prevent retrograde flow) and extend
the graft into the external iliac artery.</p></li>
<li><p>If this is an issue bilaterally, an iliac branch device can
assist in maintaining perfusion into the hypogastric
arteries.</p></li>
</ul></li>
</ul></li>
</ul>
<div id="evar" class="section level3" number="4.3.1">
<h3><span class="header-section-number">4.3.1</span> EVAR</h3>
<p><strong>Can you briefly go over the steps of an EVAR?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>EVAR now accounts for approximately 70-80% of elective abdominal
aortic aneurysm repairs and 65% of iliac aneurysm repairs in the
United States and many other countries.</p></li>
<li><p>Performed in the operating room or IR suite with a fixed or portable
C-arm</p></li>
<li><p>Anesthesia</p>
<ul>
<li>Regional block, local anesthesia or general anesthesia depending
on surgeon preference and patient risk</li>
</ul></li>
<li><p>Groin access and short sheath placement</p>
<ul>
<li><p>Percutaneous - Closure devices are introduced prior to inserting
the large sheaths containing the stent-grafts</p></li>
<li><p>Cut-down</p></li>
</ul></li>
<li><p>Pigtail catheter is used to perform an aortogram of the abdominal
aorta and iliac arteries</p></li>
<li><p>The renal artery orifices are marked. If there is any concern about
good visualization, IVUS (intravascular ultrasound) can be used to
assist.</p></li>
<li><p>Systemic heparin is given</p></li>
<li><p>Bilateral femoral sheaths are exchanged over a stiff wire for the
necessary sheaths required for the device size chosen.</p>
<ul>
<li><p>Main trunk and ipsilateral limb sheath on one side</p></li>
<li><p>Contralateral limb sheath on the other side</p></li>
</ul></li>
<li><p>The main body is positioned in the proximal neck and a repeat
angiogram is commonly performed to confirm the positioning of the
device at the desired level just below the lowest renal artery. It
is best to position the main body so that the gate is directed at
the simplest angle to cannulate.</p></li>
<li><p>The main body is deployed to the point where the gate is opened</p></li>
<li><p>Contralateral limb gate cannulation is performed using a wire and
directional catheter.</p></li>
<li><p>Once in the gate, a pigtail catheter is formed within the main body
and must be able to spin freely 360 degrees to confirm placement
within the endograft</p></li>
<li><p>The contralateral limb is introduced and deployed taking care to
preserve flow to the internal iliac artery.</p></li>
<li><p>The remainder of the main body is deployed and iliac extensions
deployed if required.</p></li>
<li><p>The stent graft is ballooned at the neck, within the gate, at the
bifurcation, and distal iliac seal zones.</p></li>
<li><p>An aortogram, usually multiple in different views, is performed to
exclude any endoleaks.</p></li>
<li><p>The sheaths are removed, and the groin sites are closed using
Perclose devices if performed percutaneously, or primary repair if
open cutdown performed.</p></li>
<li><p>Check pedal signals at the end of the case to ensure no
thromboembolic events or femoral artery access injuries have
occurred. If there is concern, an ultrasound duplex can be performed
intraoperatively.</p></li>
</ul>
<p><strong>You mentioned endoleaks, can you discuss the complications specific to
EVAR and the management?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>Many of the cardiopulmonary complications inherent with open repair
do not occur with EVAR as there is no aortic cross clamping.</p>
<ul>
<li>In a study from Mayo clinic evaluating elective infrarenal AAA
repairs from 1999 to 2001, Elkouri et al found that cardiac and
pulmonary morbidity after EVAR was drastically reduced compared
to open repair (11% vs 22% and 3% vs 16%, respectively).<span class="citation"><sup>[<a href="#ref-elkouriPerioperativeComplicationsEarly2004" role="doc-biblioref">70</a>]</sup></span></li>
</ul></li>
<li><p>Risk of ischemic colitis remains as the IMA is covered with EVAR. It
is lower than with open repair but remains 1-2%.</p></li>
<li><p>Renal insufficiency may occur secondary to contrast administration
in a patient with underlying chronic kidney disease. Thromboembolic
events may occur from thrombus-laden aortic necks with wire and
device manipulation to the renal arteries as well.</p></li>
</ul>
<div id="endoleaks" class="section level4" number="4.3.1.1">
<h4><span class="header-section-number">4.3.1.1</span> Endoleaks</h4>
<p>Defined as persistent blood flow within the aneurysm sac following EVAR.</p>
<ol style="list-style-type: decimal">
<li><p>Type I</p>
<ul>
<li><p>A leak at the graft ends secondary to inadequate seal proximally
(1a) or distally (1b)</p></li>
<li><p>If identified intraoperatively, Type I endoleaks require
attention with further balloon angioplasty, proximal or distal
extension, or endoanchors.</p></li>
<li><p>If seen in follow up surveillance, intervention is necessary.</p></li>
</ul></li>
<li><p>Type II</p>
<ul>
<li><p>Sac filling secondary to retrograde filling via a branch vessel
off of the aneurysm sac such as a lumbar artery or the IMA</p></li>
<li><p>If identified intraoperatively, this typically does not need to
be addressed in the OR.</p></li>
<li><p>Typically, type II endoleaks spontaneously thrombose and
therefore can be observed.</p></li>
<li><p>If the leak persists for &gt; 6 months with sac enlargement &gt;5mm,
intervention is recommended. Several techniques exist to
eliminate type II endoleaks, most frequently embolization.</p></li>
<li><p>It is common to continue monitoring even if there is persistent
flow as long as there is no aneurysm sac growth.</p></li>
</ul></li>
<li><p>Type III</p>
<ul>
<li><p>Separation of graft components</p></li>
<li><p>Usually identified in follow-up surveillance and necessitates
intervention.</p></li>
</ul></li>
<li><p>Type IV</p>
<ul>
<li>Secondary to a porous graft which typically does not occur any
longer as endograft material and devices have improved. If seen,
no intervention is needed at the time, and they usually
thrombose on their own.</li>
</ul></li>
<li><p>Type V</p>
<ul>
<li><p>Increasing aneurysm sac size with no identifiable endoleak.
Commonly referred to as endotension.</p></li>
<li><p>Usually necessitates graft explantation and open repair or
re-lining of the graft.</p></li>
</ul></li>
</ol>
</div>
</div>
<div id="open-repair" class="section level3" number="4.3.2">
<h3><span class="header-section-number">4.3.2</span> Open Repair</h3>
<p><strong>Now we can move onto open repair. Describe an open infrarenal aneurysm
repair.</strong><span class="citation"><sup>[<a href="#ref-garygwindAnatomicExposuresVascular2013" role="doc-biblioref">22</a>,<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>After thorough preoperative evaluation and clearance, the patient is
taken back to the operating room. An epidural may be placed
preoperatively depending on institutional preference. The patient is
intubated, and arterial and central venous catheters are placed. 
The abdomen is prepped from chest to bilateral thighs.</p></li>
<li><p>A cell-saver should be available to optimize resuscitation during
the procedure due to expected large amounts of blood loss. Balanced
resuscitation to prevent coagulopathy is important with significant
blood loss.</p></li>
<li><p>Exposure</p>
<ul>
<li>Trans-peritoneal or retro-peritoneal. First we will describe the
most common approach: trans-peritoneal.</li>
</ul></li>
<li><p>Surgical steps</p>
<ol style="list-style-type: decimal">
<li><p>Mid-line laparotomy, transverse or chevron-style incision</p></li>
<li><p>A retractor system such as an Omni, Bookwalter or Balfour
retractor is used to assist in exposure depending on physician
preference.</p></li>
<li><p>The transverse colon is retracted cephalad, and the small bowel
is retracted to the patient’s right to expose the aorta. The
duodenum is mobilized and the ligament of Treitz is divided. The
posterior peritoneum is opened along the anterior wall of the
aorta.</p></li>
<li><p>The aneurysm sac is now in view and careful dissection
proximally for clamp site is achieved. Identification of the
left renal vein crossing the aorta is key and can be divided if
necessary.</p></li>
<li><p>Identification of the renal arteries proximally is required if
there is a plan for suprarenal clamping.</p></li>
<li><p>Isolate bilateral common iliac arteries for distal clamp site.
Use caution when dissecting the fibro-areolar tissue overlying
the left common iliac artery as it contains nerves that control
sexual function. Damage can result in retrograde ejaculation.</p>
<ul>
<li><p>You can avoid nerve injury with mobilization of the sigmoid
colon medially and identifying the iliac bifurcation
distally, thus avoiding transecting the tissue overlying the
left common iliac artery.</p></li>
<li><p>If the iliac arteries are severely calcified and pose risk
for injury with clamping, intraluminal balloon catheters can
be inserted for distal control instead.</p></li>
<li><p>Also, you must be cognizant of the location of the ureters
crossing over the iliac bifurcation to prevent injury.</p></li>
</ul></li>
<li><p>After proximal and distal clamp sites have been identified,
systemic heparin is administered by anesthesia.</p></li>
<li><p>Clamp the distal vessels first to prevent distal embolization.</p></li>
<li><p>Open the aneurysm sac in a longitudinal fashion toward the
patient’s right to avoid the IMA and clear the sac of thrombus.
Extend proximally to normal aorta and then t off the incision on
the aortic wall.</p>
<ul>
<li>Some physicians prefer to transect the aortic wall as
opposed to leaving the posterior wall intact for the
anastomosis. </li>
</ul></li>
<li><p>Lumbar arteries on the posterior wall are ligated using
figure-of-eight sutures.</p>
<ul>
<li>Back-bleeding lumbar vessels can be the source of
significant blood loss.</li>
</ul></li>
<li><p>Graft</p>
<ul>
<li><p>A tube graft or bifurcated graft depending on the patient’s
anatomy and aortic diameter is chosen. Dacron or PTFE grafts
are most common, and the choice depends on physician
preference. This is anastomosed proximally in a continuous
fashion.</p></li>
<li><p>Once complete, the graft is flushed forward to flush out any
thrombus. The graft is then clamped and the aortic clamp
removed to test the anastomosis. Repair if needed.</p></li>
<li><p>The distal anastomosis is completed to the aorta or
bilateral iliac arteries depending on extent of the
aneurysm.</p></li>
<li><p>The graft is flushed forward prior to completion to remove
any thrombus within the graft. The anastomosis is completed
and clamps removed. </p></li>
</ul></li>
<li><p>Hypotension may occur at this point from re-perfusion of the
lower extremities and pelvis. Anesthesia should be notified that
unclamping will occur soon prior to completion of the distal
anastomosis to allow for fluid resuscitation in preparation.</p>
<ul>
<li>The graft can be slowly unclamped or partially clamped to
assist with blood pressure management during this time. You
can also place manual pressure on the iliac arteries or
femoral arteries to slowly release flow and avoid
significant hypotension.</li>
</ul></li>
<li><p>Next, the IMA must be addressed. The IMA orifice is identified
within the aneurysm sac. </p>
<ul>
<li><p>Chronically occluded or pulsatile back bleeding -&gt; ligate.</p></li>
<li><p>Anything between occlusion and strong pulsatile back
bleeding requires further evaluation. This should be
performed at the end of the case after the internal iliacs
have been reperfused. Methods to measure perfusion:</p>
<ul>
<li><p>Place vessel loops or micro bulldog on IMA and assess
the sigmoid colon. If there is a poor doppler signal on
the antimesenteric border of the sigmoid colon, the IMA
should be reimplanted.</p></li>
<li><p>Insert blunt-tip needle through the IMA orifice and pull
vessel loop around needle to secure and connect to a
transducer. Pressure less than 35 mmHg requires
reimplantation.<span class="citation"><sup>[<a href="#ref-hoballahInferiorMesentericArtery2021" role="doc-biblioref">71</a>]</sup></span></p></li>
</ul></li>
<li><p>The Carrel patch technique involves excising a circular
button of the aortic wall around the IMA and anastomosing it
to the graft wall.</p></li>
<li><p>Newer studies have shown that IMA reimplantation does not
eliminate the risk of ischemic colitis after open AAA
repair. In a study out of George Washington University in DC
published in JVS in 2019, there was still significant risk
of ischemic colitis rates with IMA reimplantation.<span class="citation"><sup>[<a href="#ref-leeInferiorMesentericArtery2019" role="doc-biblioref">72</a>]</sup></span></p>
<ul>
<li><p>Using NSQIP data collected prospectively and studied
retrospectively</p></li>
<li><p>Out of 2397 patients undergoing AAA from 2012-2015, 135
patients (5.6%) had ischemic colitis.</p></li>
<li><p>672 patients were evaluated further after exclusion
criteria applied (suprarenal clamp, emergent or
ruptured, occluded mesenteric vessels)</p></li>
<li><p>Of these, 637 patients had IMA ligation, 35 had IMA
reimplantation</p></li>
<li><p>Reimplantation was associated with - More frequent
return to the OR (20% vs 7.2%), Higher rates of wound
complications (17.1% vs 3%), Higher rates of ischemic
colitis (8.6% vs 2.4%)</p></li>
</ul></li>
<li><p>Difficult to interpret impact of revascularization of IMA on
ischemic colitis rates, due to selection bias, but should be
noted that patients who require revascularization still may
experience colon ischemia.</p></li>
</ul></li>
<li><p>To finish, the aneurysm sac is then closed over the graft to
protect the viscera, and the retro-peritoneum is reapproximated.
Occasionally, a vascularized omental pedicle flap may be used to
separate the graft from the duodenum to prevent an aorto-enteric
fistula if the peritoneum cannot be closed securely.</p></li>
</ol></li>
<li><p>Steps for the retro-peritoneal approach:</p>
<ul>
<li><p>Positioned semi-lateral with the left side up with bilateral
groins exposed for femoral artery access. This is done in a lazy
lateral position where the patients upper body is near complete
lateral but the hips are rotated to the patient’s left in
attempt to keep both groins in the field in case they need to be
accessed.</p></li>
<li><p>An oblique incision extends from the left 11th intercostal space
or tip of the 12th rib to the edge of the rectus abdominus
muscle, through the external and internal oblique muscles,
transversalis fascia until you are just superficial to the
peritoneum. Using blunt finger dissection, the peritoneum is
dissected from the abdominal wall posteriorly over the psoas
muscle until the aorta is reached.</p>
<ul>
<li><p>Benefits include less postoperative ileus, less
intraoperative hypothermia, lower IV fluid requirements, and
less post-op respiratory compromise.</p></li>
<li><p>A disadvantage is the difficulty addressing the right iliac
artery from this approach.</p></li>
</ul></li>
</ul></li>
</ul>
<div id="complications" class="section level4" number="4.3.2.1">
<h4><span class="header-section-number">4.3.2.1</span> Complications</h4>
<p><strong>What are some of the complications with open aortic aneurysm repair?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>Myocardial dysfunction which is usually secondary to cardiac
ischemia or hemorrhage.</p></li>
<li><p>Abdominal compartment syndrome secondary to coagulopathic bleeding
postoperatively or third spacing of fluids can cause abdominal
compartment syndrome requiring emergent laparotomy. Unexplained
oliguria, difficulty maintaining adequate ventilation, and
hypotension with significant abdominal distension is concerning for
abdominal compartment syndrome. A sustained bladder pressure &gt; 20
mmHg with associated organ dysfunction (elevated peak airway
pressures, new onset acute renal failure) is indicative of abdominal
compartment syndrome.</p>
<ul>
<li><p>Abdominal compartment syndrome can still occur after EVAR during
an aortic rupture, therefore, one must keep a heightened
suspicion for this in the post-operative period.</p></li>
<li><p>It is important to note that a patient with a soft abdominal
exam can still have abdominal compartment syndrome particularly
with an enlarged body habitus.</p></li>
</ul></li>
<li><p>Renal failure can occur due to suprarenal aortic clamping,
atheromatous embolization or hypotension causing acute tubular
necrosis (ATN).</p></li>
<li><p>Postoperative ileus is common. Duodenal obstruction from dissection
of the ligament of Treitz can mimic a gastric outlet obstruction.</p></li>
<li><p>Ischemic colitis of the left colon and rectum is the most serious
gastrointestinal complication, and the incidence ranges from 0.2 -
10%.</p>
<ul>
<li><p>3-4x more common after operations for occlusive disease than
aneurysmal disease.</p></li>
<li><p>It is important to study the collateral pathways on the
preoperative CT scan and the patient’s history to assist in
surgical decisions regarding IMA reimplantation including:</p>
<ul>
<li><p>Stenosis/occlusion of the SMA</p></li>
<li><p>Previous colectomy</p></li>
<li><p>Hypogastric artery occlusion</p></li>
</ul></li>
<li><p>Earliest manifestation is postoperative diarrhea, especially
bloody diarrhea.</p></li>
<li><p>Sigmoidoscopy is needed for diagnosis.</p>
<ul>
<li><p>Mild colon ischemia with patchy mucosal involvement should
be treated with bowel rest, fluid resuscitation and
antibiotics. Transmural necrosis requires emergent operation
with colon resection. Patients can be left in discontinuity
or an end colostomy performed depending on stability.</p></li>
<li><p>The mortality rate with colon ischemia after aneurysm
surgery is about 25% but reaches over 50% if bowel resection
is required.<span class="citation"><sup>[<a href="#ref-brewsterIntestinalIschemiaComplicating1991" role="doc-biblioref">73</a>]</sup></span>
This is a very heavily tested topic for both general surgery
and vascular surgery boards.</p></li>
</ul></li>
</ul></li>
<li><p>Distal ischemia from embolization downstream can lodge in larger
vessels or cause microembolization, colloquially known as “trash
foot.”</p></li>
<li><p>Infection is rare but can be associated with graft-enteric fistula
which is another highly tested topic.</p></li>
</ul>
</div>
<div id="postoperative-surveillance" class="section level4" number="4.3.2.2">
<h4><span class="header-section-number">4.3.2.2</span> Postoperative Surveillance</h4>
<p><strong>What is the post-operative surveillance required for open and
endovascular approach, and how do they differ?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>]</sup></span></p>
<ul>
<li><p>That is a great question because it highlights why open repair has
continued to be so important, especially for young, healthy
patients.</p></li>
<li><p>Post-operative surveillance is necessary in the immediate
post-operative period for open repair to evaluate incisions.
Follow-up is only needed every 5-10 years, unless the patient
becomes symptomatic.</p></li>
<li><p>In contrast, EVAR patients require a strict postoperative
surveillance regimen to allow for detection of endoleaks, aneurysm
sac expansion, stent fracture, limb kinking and material fatigue.</p>
<ul>
<li><p>CT scans at 1-, 6- and 12-month intervals initially then
annually are recommended which raises concerns related to cost,
cumulative radiation exposure, and contrast administration.</p></li>
<li><p>Some physicians may elect to use ultrasound for surveillance
with CTA prompted if an endoleak is identified or the sac is
enlarged, particularly in patients with stable aneurysms.</p></li>
<li><p>The long-term follow-up is often inconsistent and a study of
19,962 Medicare beneficiaries undergoing EVAR from 2001 to 2008
showed that 50% of patients were lost to annual imaging
follow-up at 5 years after
surgery.<span class="citation"><sup>[<a href="#ref-schanzerFollowUpComplianceEndovascular2015" role="doc-biblioref">74</a>]</sup></span></p></li>
</ul></li>
<li><p>Some patients will elect for open repair to avoid frequent
surveillance if they are a candidate for both, while other patients
will select endovascular management to avoid the short-term effects
like longer hospitalizations, post-operative pain, and longer
recovery time to baseline functioning in open surgery.</p></li>
</ul>
</div>
</div>
<div id="ruptured-aneurysms" class="section level3" number="4.3.3">
<h3><span class="header-section-number">4.3.3</span> Ruptured Aneurysms</h3>
<p><strong>Although elective repair is important, can you touch on the management
of a ruptured AAA (RAAA) as our last topic of the session?</strong><span class="citation"><sup>[<a href="#ref-mooreVascularEndovascularSurgery2019" role="doc-biblioref">57</a>,<a href="#ref-lindsayChapter74Ruptured2019" role="doc-biblioref">75</a>]</sup></span></p>
<ul>
<li><p>Ruptured AAAs have declined secondary to improved medical
management, decreased rates of smoking and superior diagnostic
imaging and surveillance.</p></li>
<li><p>Traditionally, it has been taught that 50% of ruptured AAAs die in
the field and of those remaining, 50% will die in the hospital. With
time, the in-hospital mortality rate has decreased.</p>
<ul>
<li>In one study out of Finland, of 712 patients with ruptured AAAs
from 2003-2013, 52% died prior to arrival to the hospital. Of
those that were offered surgery, 67% of patients were alive at
30 days indicating a mortality rate of 33%.<span class="citation"><sup>[<a href="#ref-lainePopulationbasedStudyRuptured2016" role="doc-biblioref">76</a>]</sup></span></li>
</ul></li>
<li><p>Diagnostic triad on presentation:</p>
<ul>
<li>Pain, syncope and known or palpable AAA.</li>
</ul></li>
<li><p>When a ruptured AAA is suspected or diagnosed, permissive
hypotension is key in the initial management before surgery.</p>
<ul>
<li><p>Allowing systolic arterial pressures of 50-70 mmHg as long as
the patient is mentating appropriately.</p></li>
<li><p>Limits internal bleeding which further limits loss of platelets
and clotting factors.</p></li>
</ul></li>
<li><p>Initial management involves many considerations like patient
stability, patient’s anatomy and the surgeon’s experience with
either open or endovascular repair.</p></li>
<li><p>Due to the developments of endovascular techniques, it is ideal to
have a CTA prior to the operating room to determine if the patient
is a candidate for an EVAR.</p></li>
<li><p>There are two options for expedient aortic control in an unstable
patient with a ruptured aneurysm.</p>
<ul>
<li><p>Open supraceliac aortic clamping</p>
<ul>
<li><p>Achieved by retracting the stomach caudally, entering and
dividing a portion of the gastrohepatic ligament, reaching
under and medial to the caudate lobe, dividing the pars
flaccida, and identifying the spine. The aorta lies to the
patient’s left of the spine and is bluntly dissected
anteriorly and laterally for aortic clamp placement.</p></li>
<li><p>Another method of supraceliac exposure and control is to
mobilize and reflect the left lobe of the liver, sweep the
esophagus to the patient’s left, divide the right crus of
the diaphragm and bluntly dissect both sides of the aorta
then apply the clamp.</p></li>
<li><p>A nasogastric tube can help identify the esophagus when
placing this clamp to ensure the esophagus has been swept to
the patient’s left and protected.</p></li>
<li><p>The clamp should be moved down to the desired position for
repair (supra or infrarenal depending on anatomy of the
aneurysm neck) to decrease ischemia time to visceral vessels
as soon as possible.</p></li>
</ul></li>
<li><p>Percutaneous occlusive aortic balloon</p>
<ul>
<li>Gain percutaneous access and place an occlusive aortic
balloon for stabilization in the distal thoracic aorta. This
will require a long support sheath, usually 12fr in size, to
prevent distal migration of the occlusive balloon.</li>
</ul></li>
</ul></li>
<li><p>EVAR has been used increasingly to treat ruptured AAAs and offers
many theoretical advantages over open repair.</p></li>
<li><p>Less invasive, eliminates risk of damage to periaortic and abdominal
structures, decreases bleeding from surgical dissection, minimizes
hypothermia and third space losses, and lessens the requirement for
deep anesthesia.</p></li>
<li><p>EVAR has been deemed superior to open repair for the treatment of
RAAA in many studies.</p>
<ul>
<li><p>In a study out of UVA published in JVS in August 2020, they
looked at ruptures in the VQI database from 2003-2018. This
resulted in 724 pairs of open and endovascular pairs after
propensity matching.<span class="citation"><sup>[<a href="#ref-wangEndovascularRepairRuptured2020a" role="doc-biblioref">77</a>]</sup></span></p>
<ul>
<li><p>There was a clear advantage of endovascular compared to open
repair in patient’s with suitable anatomy.</p></li>
<li><p>Length of stay was decreased with 5 vs 10 days in open. 30
day mortality was much lower at 18% vs 32%. Major adverse
events like MI, Renal failure, leg ischemia, mesenteric
ischemia, respiratory complications were much lower in the
EVAR group at 35% vs 68% in the open group.</p></li>
<li><p>All cause 1 year survival was much higher with EVAR at 73%
vs 59% in the open group.</p></li>
</ul></li>
</ul></li>
<li><p>Despite improved RAAA results with EVAR, conversion from EVAR to
open AAA repair appears to have the most unfavorable outcomes in
terms of mortality.</p>
<ul>
<li><p>Conversions can be early or late and are due to access-related
problems, errors in endograft deployment, graft migration,
persistent endoleak, graft thrombosis, or infection.</p></li>
<li><p>In a study evaluating 32,164 patients from NSQIP with 300
conversions (7,188 standard open repairs and 24,676 EVARs),
conversion to open repair was associated with a significantly
higher 30-day mortality than standard open repair (10% vs 4.2%)
and EVAR (10% vs 1.7%). In addition, conversion patients
compared to standard open patients were more likely to undergo
new dialysis (6.0% vs. 3.5%), cardiopulmonary resuscitation
(5.3% vs. 1.9%), postoperative blood transfusion (42.3% vs.
31.6%), and have a myocardial infarction (5.0% vs. 2.2%).<span class="citation"><sup>[<a href="#ref-ulteeConversionEVAROpen2016" role="doc-biblioref">78</a>]</sup></span></p></li>
</ul></li>
</ul>

</div>
</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent" line-spacing="2">
<div id="ref-garygwindAnatomicExposuresVascular2013" class="csl-entry">
22. Gary G Wind, &amp; R. James Valentine. (2013). <em>Anatomic <span>Exposures</span> in <span>Vascular Surgery</span></em> (Second). <span>Lippincott Williams &amp; Wilkins</span>.
</div>
<div id="ref-mooreVascularEndovascularSurgery2019" class="csl-entry">
57. Moore, W. S., Lawrence, P. F., &amp; Oderich, G. S. (Eds.). (2019). <em>Vascular and endovascular surgery: A comprehensive review</em> (Ninth edition). <span>Elsevier/Saunders</span>.
</div>
<div id="ref-duffyPoplitealAneurysms10year1998" class="csl-entry">
58. Duffy, S. T., Colgan, M. P., Sultan, S., Moore, D. J., &amp; Shanik, G. D. (1998). Popliteal <span>Aneurysms</span>: A 10-year <span>Experience</span>. <em>European Journal of Endovascular Surgery</em>, <em>16</em>, 218–222. <a href="https://doi.org/10.1016/s1078-5884(98)80223-2">https://doi.org/10.1016/s1078-5884(98)80223-2</a>
</div>
<div id="ref-tuvesonPatientsAbdominalAortic2016" class="csl-entry">
59. Tuveson, V., Löfdahl, H. E., &amp; Hultgren, R. (2016). Patients with abdominal aortic aneurysm have a high prevalence of popliteal artery aneurysms. <em>Vascular Medicine</em>, <em>21</em>(4), 369–375. <a href="https://doi.org/10.1177/1358863X16648404">https://doi.org/10.1177/1358863X16648404</a>
</div>
<div id="ref-diwanIncidenceFemoralPopliteal2000" class="csl-entry">
60. Diwan, A., Sarkar, R., Stanley, J. C., Zelenock, G. B., &amp; Wakefield, T. W. (2000). Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysms. <em>Journal of Vascular Surgery</em>, <em>31</em>(5), 863–869. <a href="https://doi.org/10.1067/mva.2000.105955">https://doi.org/10.1067/mva.2000.105955</a>
</div>
<div id="ref-newtonAssociationFluoroquinoloneUse2021a" class="csl-entry">
61. Newton, E. R., Akerman, A. W., Strassle, P. D., &amp; Kibbe, M. R. (2021). Association of <span class="nocase">Fluoroquinolone Use With Short-term Risk</span> of <span>Development</span> of <span>Aortic Aneurysm</span>. <em>JAMA Surgery</em>, <em>156</em>(3), 264. <a href="https://doi.org/10.1001/jamasurg.2020.6165">https://doi.org/10.1001/jamasurg.2020.6165</a>
</div>
<div id="ref-parkinsonRuptureRatesUntreated2015" class="csl-entry">
62. Parkinson, F., Ferguson, S., Lewis, P., Williams, I. M., &amp; Twine, C. P. (2015). Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair. <em>Journal of Vascular Surgery</em>, <em>61</em>(6), 1606–1612. <a href="https://doi.org/10.1016/j.jvs.2014.10.023">https://doi.org/10.1016/j.jvs.2014.10.023</a>
</div>
<div id="ref-chaikofSocietyVascularSurgery2018a" class="csl-entry">
63. Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., Oderich, G. S., Patel, M. S., Schermerhorn, M. L., &amp; Starnes, B. W. (2018). The <span>Society</span> for <span>Vascular Surgery</span> practice guidelines on the care of patients with an abdominal aortic aneurysm. <em>Journal of Vascular Surgery</em>, <em>67</em>(1), 2–77.e2. <a href="https://doi.org/10.1016/j.jvs.2017.10.044">https://doi.org/10.1016/j.jvs.2017.10.044</a>
</div>
<div id="ref-kristmundssonMorphologySmallAbdominal2016" class="csl-entry">
64. Kristmundsson, T., Dias, N., Resch, T., &amp; Sonesson, B. (2016). Morphology of <span>Small Abdominal Aortic Aneurysms Should</span> be <span>Considered</span> before <span>Continued Ultrasound Surveillance</span>. <em>Annals of Vascular Surgery</em>, <em>31</em>, 18–22. <a href="https://doi.org/10.1016/j.avsg.2015.09.016">https://doi.org/10.1016/j.avsg.2015.09.016</a>
</div>
<div id="ref-fairman72AortoiliacAneurysms2019" class="csl-entry">
65. Fairman, R. M. (2019). 72. <span>Aortoiliac Aneurysms</span>: <span>Endovascular Treatment</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em>. <span>Elsevier Inc.</span>
</div>
<div id="ref-greenhalghComparisonEndovascularAneurysm2004" class="csl-entry">
66. Greenhalgh, R. (2004). Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (<span>EVAR</span> trial 1), 30-day operative mortality results: Randomised controlled trial. <em>The Lancet</em>, <em>364</em>(9437), 843–848. <a href="https://doi.org/10.1016/S0140-6736(04)16979-1">https://doi.org/10.1016/S0140-6736(04)16979-1</a>
</div>
<div id="ref-prinssenRandomizedTrialComparing2004" class="csl-entry">
67. Prinssen, M., Cuypers, P. W. M., &amp; Buskens, E. (2004). A <span>Randomized Trial Comparing Conventional</span> and <span>Endovascular Repair</span> of <span>Abdominal Aortic Aneurysms</span>. <em>The New England Journal of Medicine</em>, 13.
</div>
<div id="ref-lederleOpenEndovascularRepair2019" class="csl-entry">
68. Lederle, F. A., Kyriakides, T. C., Stroupe, K. T., Freischlag, J. A., Padberg, F. T., Matsumura, J. S., Huo, Z., &amp; Johnson, G. R. (2019). Open versus <span>Endovascular Repair</span> of <span>Abdominal Aortic Aneurysm</span>. <em>New England Journal of Medicine</em>, <em>380</em>(22), 2126–2135. <a href="https://doi.org/10.1056/NEJMoa1715955">https://doi.org/10.1056/NEJMoa1715955</a>
</div>
<div id="ref-rajendranLateRuptureAbdominal2017" class="csl-entry">
69. Rajendran, S., &amp; May, J. (2017). Late rupture of abdominal aortic aneurysm after endovascular repair. <em>Journal of Vascular Surgery</em>, <em>65</em>(1), 52–57. <a href="https://doi.org/10.1016/j.jvs.2016.05.090">https://doi.org/10.1016/j.jvs.2016.05.090</a>
</div>
<div id="ref-elkouriPerioperativeComplicationsEarly2004" class="csl-entry">
70. Elkouri, S., Gloviczki, P., McKusick, M. A., Panneton, J. M., Andrews, J., Bower, T. C., Noel, A. A., Harmsen, W. S., Hoskin, T. L., &amp; Cherry, K. (2004). Perioperative complications and early outcome after endovascular and open surgical repair of abdominal aortic aneurysms. <em>Journal of Vascular Surgery</em>, <em>39</em>(3), 497–505. <a href="https://doi.org/10.1016/j.jvs.2003.10.018">https://doi.org/10.1016/j.jvs.2003.10.018</a>
</div>
<div id="ref-hoballahInferiorMesentericArtery2021" class="csl-entry">
71. Hoballah, J. J. (2021). Inferior <span>Mesenteric Artery Reimplantation</span>. In J. J. Hoballah &amp; C. F. Bechara (Eds.), <em>Vascular <span>Reconstructions</span></em> (pp. 373–379). <span>Springer New York</span>. <a href="https://doi.org/10.1007/978-1-0716-1089-3_17">https://doi.org/10.1007/978-1-0716-1089-3_17</a>
</div>
<div id="ref-leeInferiorMesentericArtery2019" class="csl-entry">
72. Lee, K. B., Lu, J., Macsata, R. A., Patel, D., Yang, A., Ricotta, J. J., Amdur, R. L., Sidawy, A. N., &amp; Nguyen, B.-N. (2019). Inferior mesenteric artery replantation does not decrease the risk of ischemic colitis after open infrarenal abdominal aortic aneurysm repair. <em>Journal of Vascular Surgery</em>, <em>69</em>(6), 1825–1830. <a href="https://doi.org/10.1016/j.jvs.2018.09.046">https://doi.org/10.1016/j.jvs.2018.09.046</a>
</div>
<div id="ref-brewsterIntestinalIschemiaComplicating1991" class="csl-entry">
73. Brewster, D. C., Franklin, D. P., Cambria, R. P., Darling, R. C., Moncure, A. C., Lamuraglia, G. M., Stone, W. M., &amp; Abbott, W. M. (1991). Intestinal ischemia complicating abdominal aortic surgery. <em>Surgery</em>, <em>109</em>(4), 447–454.
</div>
<div id="ref-schanzerFollowUpComplianceEndovascular2015" class="csl-entry">
74. Schanzer, A., Messina, L. M., Ghosh, K., Simons, J. P., Robinson, W. P., Aiello, F. A., Goldberg, R. J., &amp; Rosen, A. B. (2015). Follow-<span>Up Compliance After Endovascular Abdominal Aortic Aneurysm Repair</span> in <span>Medicare Beneficiaries</span>. <em>Journal of Vascular Surgery</em>, <em>61</em>(1), 16–22.e1. <a href="https://doi.org/10.1016/j.jvs.2014.06.006">https://doi.org/10.1016/j.jvs.2014.06.006</a>
</div>
<div id="ref-lindsayChapter74Ruptured2019" class="csl-entry">
75. Lindsay, T. F. (2019). Chapter 74 - <span>Ruptured Aortoiliac Aneurysms</span> and <span>Their Management</span>. In <em>Rutherford’s <span>Vascular Surgery</span> and <span>Endovascular Therapy</span></em> (Ninth, p. 21). <span>Elsevier Inc.</span>
</div>
<div id="ref-lainePopulationbasedStudyRuptured2016" class="csl-entry">
76. Laine, M. T., Laukontaus, S. J., Kantonen, I., &amp; Venermo, M. (2016). Population-based study of ruptured abdominal aortic aneurysm. <em>British Journal of Surgery</em>, <em>103</em>(12), 1634–1639. <a href="https://doi.org/10.1002/bjs.10200">https://doi.org/10.1002/bjs.10200</a>
</div>
<div id="ref-wangEndovascularRepairRuptured2020a" class="csl-entry">
77. Wang, L. J., Locham, S., Al-Nouri, O., Eagleton, M. J., Clouse, W. D., &amp; Malas, M. B. (2020). Endovascular repair of ruptured abdominal aortic aneurysm is superior to open repair: <span class="nocase">Propensity-matched</span> analysis in the <span>Vascular Quality Initiative</span>. <em>Journal of Vascular Surgery</em>, <em>72</em>(2), 498–507. <a href="https://doi.org/10.1016/j.jvs.2019.11.063">https://doi.org/10.1016/j.jvs.2019.11.063</a>
</div>
<div id="ref-ulteeConversionEVAROpen2016" class="csl-entry">
78. Ultee, K. H. J., Soden, P. A., Zettervall, S. L., Darling, J., Verhagen, H. J. M., &amp; Schermerhorn, M. L. (2016). Conversion from <span>EVAR</span> to <span>Open Abdominal Aortic Aneurysm Repair</span>. <em>Journal of Vascular Surgery</em>, <em>64</em>(1), 76–82. <a href="https://doi.org/10.1016/j.jvs.2015.12.055">https://doi.org/10.1016/j.jvs.2015.12.055</a>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="upper-extremity-and-thoracic-outlet.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="lower-extremity-occlusive-disease.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": false,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": false,
"email": true
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/adam-mdmph/VS-Board-Review/blob/main/03-abdominal-anuerysms.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true
},
"info": false
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
